» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics (PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

MONGOL EM IMPEX

WVB Number : MNG000040090 Country : Mongolia
SIC categorization : DRUGS AND PROPRIETARY-WHSL (5122) ISIN : N/A
FT categorization : DRUGS (433)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Mongolemimpex Concern established in 1923, Mongolian People's Government ordered into existence the Pharmaceutics Preparation Facility. This former state-owned pharmaceutical supply institution underwent several restructurings, but none was as fundamental as the recent one, in its 85 years a history. By the end of 2006, the company has been privatized to Bishrelt Holding.
Phone : 976 11-323961 Fax : 11-323877
Chairman: : ARIUNBOLD A Auditor :
CEO/Managing Director : BOLORMAA B

» Company Facts

Net Profit Margin (%) 0.06  
Operating Margin (%) 1.19  
Return on Assets (%) 0.04  
Return on Equity (%) 0.04  
Employees N/A  

» Company Financials

  Annual (2006)
Income Statement
('000 MNT )
Sales/Total Revenue 3,159,651  
EBITDA 128,247  
EBIT 47,280  
Net Income 1,780  
Balance Sheet
( '000 MNT)
Total Current Assets 3,398,795  
Total Assets 4,643,608  
Current Liabilities 113,644  
Total Liabilities & Debt 392,504  
Total Equity 4,251,104  
Cash & Flow
( '000 MNT)
Net Income/Staring Line 1,780  
Cash from Operating 250,348  
Cash from Investing -81,246  
Cash from Financing 0  
Cash & Equivalent Yr End 604,130